GC-78-HCl

N/A

Report date: 2023/11/24 16:30:44
NME

Base Information

Drug NameGC-78-HCl
Drug Alias NameGC-78-HCl
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSARS-CoV-2-3C-like-proteinase inhibitors
TargetsSARS-CoV-2-3C-like-proteinase
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Human Coronavirus OC43 InfectionsHuman Coronavirus 229E Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSchool of Pharmaceutical Sciences of Shandong UniversityShenzhen Research Institute of Shandong University
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Research Institute of Shandong UniversitySchool of Pharmaceutical Sciences of Shandong University
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Human Coronavirus OC43 InfectionsHuman Coronavirus 229E Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A